Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. D. Anderson, C. P. Perry, H. Fox, B. Charlton (Camperdown, Sydney, Australia). The maximum % fall in FEV₁ after a mannitol challenge in subjects with asthma, suspected asthma, COPD and bronchiectasis. Eur Respir J 2010; 36: Suppl. 54, 239

Member's Comments

No comment yet.

Related content which might interest you: COPD and asthma patients: what can they expect of high altitude residences? Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases Year: 2006 Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007 A comparison of clinical characteristics between cough variant asthma (CVA) and bronchial asthma (BA) in adult patients Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010 Mechanisms of exacerbation of respiratory symptoms in patients with COPD Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 The clinical significance and frequency of bronchiectasis in COPD patients Source: International Congress 2016 – Monitoring comorbidities Year: 2016 COPD and asthma overlap with bronchiectasis Source: Eur Respir Monogr 2018; 81: 167-185 Year: 2018 Airway remodelling augmented in patients with asthma COPD overlap (ACO) compared to asthma and COPD. Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Eosinophilic airway inflammation as a complication of COPD, and the usefulness of ICS on these cases Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Asthma control or asthma severity Year: 2008 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Additional value of spirometry in risk assessment of acute respiratory disease in winter among patients with mild to moderate asthma or COPD Source: Eur Respir J 2002; 20: Suppl. 38, 473s Year: 2002 Efficacy of administration of 0.02% solution of decamethoxine via nebulizer in patients with infectious exacerbations of COPD Source: Annual Congress 2013 –COPD treatment Year: 2013 Omalizumab reduces asthma exacerbations in children (6–<12 years) with moderate-to-severe allergic (IgE-mediated) asthma irrespective of baseline LABA use Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Inhalation characteristics of asthmatic children (child), adults asthmatics (adult) and chronic obstructive pulmonary disease patients when they inhale through a spiromax dry powder inhaler (DPI) Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009 Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Symptom profile of exacerbations in earlier and later COPD Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013